Chimerix Stock (NASDAQ: CMRX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 515.00 / 473.23K |
Day Range | - - - |
52 Wk Range | 0.75 - 1.30 |
Market Cap | $79.79M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | 2.36% |
Days to Cover | 1.28 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Chimerix (NASDAQ:CMRX) through any online brokerage.
Other companies in Chimerix’s space includes: Renovaro (NASDAQ:RENB), bluebird bio (NASDAQ:BLUE), Cellectar Biosciences (NASDAQ:CLRB), Armata Pharmaceuticals (AMEX:ARMP) and Gritstone Bio (NASDAQ:GRTS).
Chimerix has a consensus price target of $7.75.
The stock price for Chimerix (NASDAQ: CMRX) is $0.8901 last updated September 23, 2024 at 7:00 AM EDT.
There are no upcoming dividends for Chimerix.
Chimerix’s Q3 earnings are confirmed for Thursday, October 31, 2024.
There is no upcoming split for Chimerix.
Chimerix is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.